Almajali Fawwaz, Oleary Catherine, Hallcox Taylor, Lok Justin, Hermelin Daniela, Guenette Alexis, Nazzal Mustafa
Department of Surgery, Saint Louis University, St. Louis, MO, USA.
School of Medicine, Saint Louis University, St. Louis, MO, USA.
Case Rep Transplant. 2022 Jun 10;2022:3062836. doi: 10.1155/2022/3062836. eCollection 2022.
Ehrlichia infection has a broad spectrum of diseases ranging from asymptomatic to fatal. While Ehrlichia often presents as a mild form of the disease in immunocompetent patients, immunosuppressed patients are at increased risk for a more virulent and potentially fatal infection. Our liver transplant patient presented with fever, persistent headaches, and negative Ehrlichia antibodies. Empiric antibiotic therapy was started and along with knowledge of prior tick infection, doxycycline was added. Subsequent positive PCR and observation of Ehrlichia chaffeensis in peripheral blood smear confirmed the diagnosis. The patient did recover from infection but not before it manifested in hepatic, renal, and pulmonary involvement. Therefore, a high level of suspicion is necessary for early detection and treatment initiation to prevent a devastating progression of the disease in immunosuppressed patients.
埃立克体感染可导致从无症状到致命的广泛疾病谱。虽然埃立克体在免疫功能正常的患者中通常表现为疾病的轻度形式,但免疫抑制患者发生更具毒性且可能致命感染的风险增加。我们的肝移植患者出现发热、持续性头痛,埃立克体抗体检测为阴性。开始了经验性抗生素治疗,并结合既往蜱虫感染史,加用了强力霉素。随后外周血涂片PCR检测呈阳性且观察到恰菲埃立克体,确诊了该病。患者最终从感染中康复,但在此之前已出现肝脏、肾脏和肺部受累。因此,对于免疫抑制患者,必须高度怀疑以尽早发现并开始治疗,防止疾病的灾难性进展。